07:17 AM EDT, 05/17/2012 (MidnightTrader) -- Rosetta Genomics (ROSG:$4.99,00$3.37,00208.02%) entered into definitive agreements with investors to purchase an aggregate of 632,057 ordinary shares at a price of $3.50 per share in a registered direct offering. The offering is expected to close on or about May 22, 2012, subject to the satisfaction of customary closing conditions.